These Analysts Cut Their Forecasts On Dave & Buster's After Downbeat Q2 Results

Dave & Buster's Entertainment Inc (PLAY) reported weaker-than-expected second-quarter results, with revenue of $557.41 million missing analyst estimates of $562.78 million and adjusted earnings per share of 40 cents falling significantly short of the 92-cent estimate. Following the announcement, the company's shares dropped 16.5% to $20.21, leading analysts such as UBS and Truist Securities to lower their price targets. Despite the miss, the company noted Q3 same-store sales trends are consistent with Q2 exit and plans to open at least five additional international franchise stores.

Analysis

Dave & Buster's Entertainment reported a significant underperformance in its second quarter, with revenue of $557.41 million missing estimates and adjusted EPS of 40 cents falling drastically short of the 92-cent consensus. This substantial earnings miss, representing a greater than 50% deviation from expectations, triggered a severe market reaction, evidenced by a 16.5% decline in the company's share price to $20.21. Forward-looking guidance provided little reassurance, as the company indicated that third-quarter same-store sales trends are merely consistent with the weak exit rate of Q2, signaling no immediate operational turnaround. While the company announced plans to open at least five international franchise stores, this small-scale expansion appears insufficient to offset the core domestic weakness. The negative sentiment was further solidified by analyst actions, with both UBS and Truist Securities lowering their price targets to $25 and $22, respectively, reflecting diminished expectations for the company's near-term performance.

Key Decisions for Investors

• Investors should exercise significant caution, as the severe Q2 earnings miss and subsequent 16.5% stock price collapse indicate a fundamental deterioration in the company's operational performance and consumer demand.
• Monitor same-store sales trends closely in the upcoming quarters, as management's guidance for Q3 points to continued weakness and a lack of near-term catalysts for a recovery.
• Consider the lowered analyst price targets from UBS ($25) and Truist ($22) as a revised performance ceiling, recognizing that while they imply some upside from the current price, the accompanying Hold/Neutral ratings suggest heightened execution risk and limited conviction in a rapid rebound.